The minimally important difference and patient acceptable symptom state for the Raynaud's condition score in patients with Raynaud's phenomenon in a large randomised controlled clinical trial

The minimally important difference and patient acceptable symptom state for the Raynaud's condition score in patients with Raynaud's phenomenon in a large randomised controlled clinical trial

Item
http://www.wikidata.org/entity/Q33724464
Phosphodiesterase-5 inhibitors for the treatment of secondary Raynaud's phenomenon: systematic review and meta-analysis of randomised trials.Minimally important differences of the gout impact scale in a randomized controlled trial.Minimally important differences of the UCLA Scleroderma Clinical Trial Consortium Gastrointestinal Tract Instrument.The Therapeutic Efficacy of Botulinum Toxin in Treating Scleroderma-Associated Raynaud's Phenomenon: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial.Evaluation of test characteristics for outcome measures used in Raynaud's phenomenon clinical trials.Difficult-to-treat gouty arthritis: a disease warranting better management.Calcium channel blockers for primary and secondary Raynaud's phenomenon.A comparison of the scaling properties of the English, Spanish, French, and Chinese EQ-5D descriptive systems.Successful treatment of Raynaud's phenomenon and digital ulcers in systemic sclerosis patients with botulinum toxin B injection: Assessment of peripheral vascular disorder by angiography and dermoscopic image of nail fold capillary.
P2860

The minimally important difference and patient acceptable symptom state for the Raynaud's condition score in patients with Raynaud's phenomenon in a large randomised controlled clinical trial

Item
http://www.wikidata.org/entity/Q33724464
description
2009 nî lūn-bûn
@nan
2009 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
The minimally important differ ...... ised controlled clinical trial
@ast
The minimally important differ ...... ised controlled clinical trial
@en
type
label
The minimally important differ ...... ised controlled clinical trial
@ast
The minimally important differ ...... ised controlled clinical trial
@en
prefLabel
The minimally important differ ...... ised controlled clinical trial
@ast
The minimally important differ ...... ised controlled clinical trial
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P5875
P698
P932
P356
P1433
P1476
The minimally important differ ...... ised controlled clinical trial
@en
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P5875
P698
P932